COVID-19 is an emerging, rapidly evolving situation Show message Get the latest public health information from CDC Get the latest research information from NIH Get the latest information and resources from NHLBI NIH staff guidance on coronavirus (NIH Only)
Blood Epidemiology and Clinical Therapeutics Funding for benign blood diseases and cell therapies (e.g., hematopoietic stem cell transplants, transfusion products, and novel cell therapies), including development and dissemination of data science resources in patient-reported outcomes. Program Officers Nancy DiFronzo, Ph.D. Stem cell transplants; GVHD; MDS nancy.difronzo@nih.gov 301-435-0065 Nahed El Kassar, M.D., Ph.D. Hematology, immunology; transfusion nahed.elkassar@nih.gov 301-435-0065 Ellen M. Werner, Ph.D., M.A. Data science; sickle cell disease ellen.werner@nih.gov 301-435-0050 Shimian Zou, Ph.D. NHLBI HIV/AIDS Coordinator shimian.zou@nih.gov 301-435-0065 Iman Martin, Ph.D., M.P.H., M.Sc iman.martin@nih.gov 301-827-5814 Funding Opportunities View all active NHLBI funding opportunities